• FormFactor, Inc. has already reported its fourth-quarter and full-year 2025 results, delivering US$215.16 million in Q4 sales and higher quarterly net income and earnings per share versus the prior year, while full-year revenue of US$784.99 million came alongside lower annual net income and earnings per share.
• Management coupled these record quarterly and annual revenues with guidance for Q1 2026 that tops analyst expectations, pointing to strong demand in high-bandwidth memory, data center-related test products, and added capacity from its new Farmers Branch facility and the Keystone Photonics acquisition.
• We’ll now look at how this upbeat high-bandwidth memory-driven guidance and operational expansion could shape FormFactor’s broader investment narrative.

AI is about to change healthcare. These 25 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

What Is FormFactor's Investment Narrative?

To own FormFactor today, you have to be comfortable with a stock that has already run very hard while leaning even further into high‑bandwidth memory and data center testing as core drivers. The latest quarter delivered record revenue and a sharp improvement in quarterly earnings, and the Q1 2026 outlook came in well ahead of prior analyst expectations, which directly reinforces the near term catalyst around HBM and advanced compute demand. At the same time, full year profit was lower than the prior year, return on equity remains modest, and the shares are trading well above both analyst and discounted cash flow fair value estimates, so execution at the new Farmers Branch facility and integration of Keystone Photonics matter more than ever. The recent news clearly raises the stakes on those expectations rather than removing the risks.

However, that recent share price surge comes with valuation and execution risks investors should be aware of. FormFactor's shares are on the way up, but they could be overextended by 42%. Uncover the fair value now.

Exploring Other Perspectives

Six Simply Wall St Community fair value estimates for FormFactor span roughly US$29 to US$88, underscoring how differently private investors are sizing up the stock. Set against Q4’s upbeat high‑bandwidth memory driven guidance and the sharp share price rise, this spread in views invites you to weigh rich valuations and execution risks before deciding where you stand.

Explore 6 other fair value estimates on FormFactor - why the stock might be worth as much as $88.00!

Build Your Own FormFactor Narrative

Disagree with this assessment? Create your own narrative in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your FormFactor research is our analysis highlighting 1 key reward that could impact your investment decision.
• Our free FormFactor research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate FormFactor's overall financial health at a glance.

Looking For Alternative Opportunities?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

• Capitalize on the AI infrastructure supercycle with our selection of the 33 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• The future of work is here. Discover the 28 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• Uncover the next big thing with 25 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.